Absorbent garment comprising dual containment flaps

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time to make sure it’s protected with a PowerPatent Utility, Provisional or Design Patent Application

The Kimberly-Clark Worldwide, Inc. patent solves the following problem:

The present invention is directed to an absorbent garment and a method for making it. In particular, the present invention is directed to an absorbent garment has two containment flap.

Our analysis of this patent is as follows:

Kimberly-Clark Worldwide, Inc.’s patent US 6110158 A deals with Absorbent garment comprising dual containment flaps.
Disclosed is an absorbent garment including a pair of outer containment flap and a pair of inner containment flap, said outer and inner containment flaps are formed from a first integral sheet containment flap of material with a length, said inner containment flaps with a length less than the length of the first sheet of the containment flap material. also described is a method of producing the absorbent garments.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Programmable control multiplexing for input/output blocks (IOBs) in FPGA integrated circuits

Protect your idea by filing a Provisional or Utility Patent Application with the PowerPatent Patent Service. It’s easy and fully backed by patent lawyers – and you don’t have to pay until you’re done.

The Vantis Corporation patent solves the following problem:

The invention is generally directed to the integrated circuit, more specifically automatic Logic Devices (PLDs), and even more specifically to a subclass of PLDs known automatic Field Gate Arrays (FPGAs).

Our analysis of this patent is as follows:

Vantis Corporation’s patent US 6107823 A deals with Programmable control multiplexing for input/output blocks (IOBs) in FPGA integrated circuits.
A first and second multiplexer with a first and second inter-connecting channel to provide control and timing signals to the plurality of IOBs.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Anti-regurgitation infant formula

Protect your idea by filing a Provisional or Utility Patent Application with the PowerPatent Patent Service. It’s easy and fully backed by patent lawyers – and you don’t have to pay until you’re done.

The Bristol-Myers Squibb Company patent solves the following problem:

Starch is composed of two distinct polymer fractions: amylose and amylopectin. Amylose is the linear particle containing -1.4 linked glucose units. Amylopectin has the same structure as amylose but some of the glucose units combined with a -1.6 relationship giving rise to a branched structure. Flour generally contain 17-24% amylose and from 76-83% amylopectin.

Our analysis of this patent is as follows:

Bristol-Myers Squibb Company’s patent US 6099871 A deals with Anti-regurgitation infant formula.
Infant formulas containing certain thickening agents useful for the treatment of regurgitation. The thickening agent may waxy maize starch, waxy rice starch, or a mixture thereof.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Variable grain architecture for FPGA integrated circuits

Be the First-to-File and Protect your earth-moving ideas with PowerPatent software service for Online Patent Application

The Lattice Semiconductor Corporation patent solves the following problem:

The invention is generally directed to the integrated circuit, more specifically the architectural and physical layouts for automatic Logic Devices (PLD), and even more specifically to a subclass of PLD's known as automatic Field Gate Arrays (FPGA ).

Our analysis of this patent is as follows:

Lattice Semiconductor Corporation’s patent US 6097212 A deals with Variable grain architecture for FPGA integrated circuits.
A variable grain architecture is revealed which variables wheat Bloke (VGB) is wedged glass together in opposition to one another to define super-VGB structures. The super-VGB structures are arranged as a matrix in a FPGA device. Each VGB includes progressive function synthesizing layers to build more complex function signal by folding together less complicated function signal to the main layers. A function that caused the layer consisting of a set of function caused lookup table (Lut) given by the periphery of the corresponding super-VGB building. In some cases, the function that caused the layer is L-shaped and includes a symmetrical distribution of configurable Building Blocks. A signal-receiving layer interface with adjacent lines connect to obtain input for terms Lut and control. A decoding layer interposed between the signal-receiving layer and the function that caused layer providing strapping and intercept functions. Each VGB have a common control section, a wide-yon section and an a-propagating section. Each super-VGB has a centrally-shared section longline driver can be obtained from any of the constituent's VGB. A diversified spectrum of graft line, including 2XL, 4xL, 8XL and directly involving surround each super-VGB to provide different types of graft.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Esters of 3-hydroxy-piperidinemethanol derivatives

You’ve invested time, talent, and energy into making a dent in the universe with your invention and ideas. Now it’s time to make sure it’s protected with a PowerPatent Utility, Provisional or Design Patent Application

The Janssen Pharmaceutica N.V. patent solves the following problem:

Our analysis of this patent is as follows:

Janssen Pharmaceutica N.V.’s patent US 6096761 A deals with Esters of 3-hydroxy-piperidinemethanol derivatives.
The present invention of compounds of formula (I), ## str1 ## a stereochemically isomeric form thereof, and an A-oxide form thereof or a pharmaceutically acceptable acid addition salt thereof, R1 is C1-6 alkyloxy, C2-6 alkenyloxy or C2 -6 alkynyloxy; R2 is hydrogen or C1-6 alkyloxy, or when taken together R1 and R2 may form a bivalent radical of formula wherein in said bivalent radicals one or two hydrogen atoms can be replaced by C1-6 alkyl; P3 is hydrogen or halo; R4 is hydrogen or C1-6 alkyl; L is C3-6 cycloalkyl, C5-6 cycloalkanone, C2-6 alkenyl optionally substituted aryl, or L is a radical of formula -Alk-R5, Alk-X – R6, -Alk-Y – C ( Oh) – P8, or -Alk-Y – C (O) – NR10 R11 where each Alk is C1-12 alkanediyl; and R5 is hydrogen, cyano, C1-6 alkylsulfonylamino, C3-6 cycloalkyl, C5-6 cycloalkanone, aryl, di (aryl) methyl or a heterocyclic ringsystem; R6 is hydrogen, C1-6 alkyl, hydroxyC1-6 alkyl, C3-6 cycloalkyl, aryl or heterocyclic ringsystem; X is O, S, SO2 or NR7; said R7 hydrogen, C1-6 alkyl or aryl; P8 is hydrogen, C1-6 alkyl, C3-6 cycloalkyl, aryl, arylC1-6 alkyl, di (aryl) methyl, C1-6 alkyloxy or hydroxy; Y is NR9 or a direct bond; said R9 hydrogen, C1-6 alkyl or aryl R10 and R11 each independently hydrogen, C1-6 alkyl, C3-6 cycloalkyl, aryl or arylC1-6 alkyl, or R10 and R11 with the nitrogen atom bearing R10 and R11 to form a pyrrolidinyl or piperidinyl ring both optionally substituted with C1-6 alkyl, amino or mono or di (C1-6 alkyl) amino, or R10 and R11 with the nitrogen bearing R10 and R11 may be build a piperazinyl or 4-morpholinyl radical both optionally substituted with C1-6 alkyl. The process of preparing said products, formulations comprising said products and their use as a medicinal expressed, in particular for treating conditions related to damages in gastric emptying.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.

Sequential separation of whey

Protect your invention by filing a Provisional or Utility Patent Application using our software today! It’s easy and fully backed by patent lawyers – and you don’t have to pay until you’re done.

The Sepragen Corporation patent solves the following problem:

The dairy industry represents a major source of income for many people throughout the world, and the dairy products represents an important source of nutrition for a majority of men and non-human the population of animals in the world in the form of milk, cheese, yogurt, and other products. In 1994, the US dairy (eggs) industry contributes approximately $ 717,000,000 to US exports. The import figures for these same commodities are $ 583,000,000 (R. Famighetti (ed.), World Almanac and Book of Facts, 1996 Funk & Wagnalls, Mahway, NJ, [1995], p. 207 ).

Our analysis of this patent is as follows:

Sepragen Corporation’s patent US 6096870 A deals with Sequential separation of whey.
The present invention is related to the separation of whey protein, particularly the continuous separation of whey protein to other pieces by using chromatography. The present invention further provides methods and compositions for the sequential separation of whey protein, as well as their use in various products. The present invention also provides methods and compositions for cleaning the chromatography resins that are used in the separation of whey protein.

The revolutionary TRAN&ASSOCIATES provides patent creation and management tools to help inventors protect their inventions using the patent system. Full lawyer support to complete and file the application is available.